
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The next major emergent infectious disease: reflections on vaccine emergency development strategies
Yu Bai, Qian Wang, Mingchen Liu, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 4, pp. 471-481
Open Access | Times Cited: 18
Yu Bai, Qian Wang, Mingchen Liu, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 4, pp. 471-481
Open Access | Times Cited: 18
Showing 18 citing articles:
Research progress on the quality control of mRNA vaccines
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 8
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 8
An improved BERT method for the evolution of network public opinion of major infectious diseases: Case Study of COVID-19
Meng Su, Dongsheng Cheng, Yan Xu, et al.
Expert Systems with Applications (2023) Vol. 233, pp. 120938-120938
Closed Access | Times Cited: 11
Meng Su, Dongsheng Cheng, Yan Xu, et al.
Expert Systems with Applications (2023) Vol. 233, pp. 120938-120938
Closed Access | Times Cited: 11
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
Sabrina Clever, Leonard Limpinsel, Christian Meyer zu Natrup, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 417-417
Open Access | Times Cited: 2
Sabrina Clever, Leonard Limpinsel, Christian Meyer zu Natrup, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 417-417
Open Access | Times Cited: 2
Location Decision of Emergency Medical Supply Distribution Centers Under Uncertain Environment
Liu Yong, Meiru Wang, Yong Wang
International Journal of Fuzzy Systems (2024) Vol. 26, Iss. 5, pp. 1567-1603
Closed Access | Times Cited: 1
Liu Yong, Meiru Wang, Yong Wang
International Journal of Fuzzy Systems (2024) Vol. 26, Iss. 5, pp. 1567-1603
Closed Access | Times Cited: 1
Tilorone and Cridanimod Protect Mice and Show Antiviral Activity in Rats despite Absence of the Interferon-Inducing Effect in Rats
Viktoriya Keyer, Laura Syzdykova, Gulzat Zauatbayeva, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 617-617
Open Access | Times Cited: 7
Viktoriya Keyer, Laura Syzdykova, Gulzat Zauatbayeva, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 617-617
Open Access | Times Cited: 7
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review
Qian Wang, Xing Wu, Qunying Mao, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 8, pp. 1119-1127
Closed Access | Times Cited: 5
Qian Wang, Xing Wu, Qunying Mao, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 8, pp. 1119-1127
Closed Access | Times Cited: 5
A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine
Dong Liu, Chaoqiang An, Yu Bai, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1854-1854
Open Access | Times Cited: 5
Dong Liu, Chaoqiang An, Yu Bai, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1854-1854
Open Access | Times Cited: 5
Development of semisynthetic saponin immunostimulants
Di Bai, Hyun Jung Kim, Pengfei Wang
Medicinal Chemistry Research (2024) Vol. 33, Iss. 8, pp. 1292-1306
Open Access
Di Bai, Hyun Jung Kim, Pengfei Wang
Medicinal Chemistry Research (2024) Vol. 33, Iss. 8, pp. 1292-1306
Open Access
Neem Seed Methanolic Extract Scavenges Free Radicals and Demonstrate Bacterial Growth Inhibition Potential
Omorefosa O. Osemwegie, Marvellous Amarachi Acho, Charles Obiora Nwonuma, et al.
(2024), pp. 1-10
Closed Access
Omorefosa O. Osemwegie, Marvellous Amarachi Acho, Charles Obiora Nwonuma, et al.
(2024), pp. 1-10
Closed Access
Infectious diseases and global security: Analysis of global control and vaccination strategies
Beata Strzelecka, Ledi Neçaj, Katarzyna Wiśniewska, et al.
Salud Ciencia y Tecnología (2024) Vol. 4
Closed Access
Beata Strzelecka, Ledi Neçaj, Katarzyna Wiśniewska, et al.
Salud Ciencia y Tecnología (2024) Vol. 4
Closed Access
Codon optimized influenza H1 HA sequence but not CTLA-4 targeting of HA antigen to enhance the efficacy of DNA vaccines in an animal model
Dito Anurogo, Chia‐Yuan Chen, Chu-Chi Lin, et al.
Journal of Immunotoxicology (2024) Vol. 21, Iss. 1
Open Access
Dito Anurogo, Chia‐Yuan Chen, Chu-Chi Lin, et al.
Journal of Immunotoxicology (2024) Vol. 21, Iss. 1
Open Access
Need What and Why: A Comparative Analysis of Behavioral Performance, Social Support of Patients in Online Health Communities
Shugang Li, Tingting Jiang
(2024), pp. 226-231
Closed Access
Shugang Li, Tingting Jiang
(2024), pp. 226-231
Closed Access
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms
Federico D’Alessio, Lucia Lione, Erika Salvatori, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 678-678
Open Access | Times Cited: 1
Federico D’Alessio, Lucia Lione, Erika Salvatori, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 678-678
Open Access | Times Cited: 1
A Novel Targeted RIG-I Receptor 5′Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine
Yu Bai, Chaoqiang An, Xuanxuan Zhang, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1099-1099
Open Access | Times Cited: 1
Yu Bai, Chaoqiang An, Xuanxuan Zhang, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1099-1099
Open Access | Times Cited: 1
The Next Pandemic: Challenges and Hopes
Cláudia Pio Ferreira, Marie-Françoise J. Doursout, Joselito S. Balingit
Springer eBooks (2023), pp. 373-391
Closed Access
Cláudia Pio Ferreira, Marie-Françoise J. Doursout, Joselito S. Balingit
Springer eBooks (2023), pp. 373-391
Closed Access
New multifunctional bromine-active polymers: synthesis, properties, and antimicrobial activity
Bohdan Murashevych, Dmitry Girenko, Mykola Toropin, et al.
Eastern-European Journal of Enterprise Technologies (2023) Vol. 2, Iss. 6 (122), pp. 32-42
Open Access
Bohdan Murashevych, Dmitry Girenko, Mykola Toropin, et al.
Eastern-European Journal of Enterprise Technologies (2023) Vol. 2, Iss. 6 (122), pp. 32-42
Open Access
Drivers for the Emergence and re-emergence of Human Infectious Diseases, A Systematic review
Temesgen File, Bayisa Chala Chala
Research Square (Research Square) (2023)
Open Access
Temesgen File, Bayisa Chala Chala
Research Square (Research Square) (2023)
Open Access
NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS
G.M. Zauatbayeva, L.R. Syzdykova, Viktoriya Keyer, et al.
Eurasian journal of applied biotechnology (2022), Iss. 2, pp. 44-53
Open Access
G.M. Zauatbayeva, L.R. Syzdykova, Viktoriya Keyer, et al.
Eurasian journal of applied biotechnology (2022), Iss. 2, pp. 44-53
Open Access